Dr. Erter is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
397 Wallace Rd
Ste 201
Nashville, TN 37211Phone+1 615-333-2481Fax+1 615-781-3923
Education & Training
- Vanderbilt University Medical CenterResidency, Internal Medicine, 2004 - 2007
- Vanderbilt University Medical CenterInternship, Internal Medicine, 2004 - 2005
- Medical University of South CarolinaClass of 2004
- Davidson CollegeBS, Chemistry, 1995 - 1999
Certifications & Licensure
- TN State Medical License 2006 - 2025
- OH State Medical License 2007 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 15 citationsCutaneous CD4+ CD56+ hematologic malignanciesCynthia M. Magro, Pierluigi Porcu, Jochen T. Schaefer, Jack W. Erter, Richard R. Furman
Journal of the American Academy of Dermatology. 2010-08-01 - 11 citationsPhase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B‐Cell Lymphoma Who Are Poor Candidates for R‐CHOP ChemotherapyIan W. Flinn, Jack Erter, Davey B. Daniel, Joseph R. Mace, Jesus G. Berdeja
The Oncologist. 2019-08-01 - 8 citationsNew targets of therapy in T-cell lymphomas.Jack W. Erter, Lapo Alinari, Kamruz Darabi, Metin N. Gurcan, Ramiro Garzon
Current Drug Targets. 2010-03-31
Press Mentions
- BlueCross BlueShield Defends New Specialty Drug Policy as Some Legislators Cry FoulJanuary 22nd, 2020
- BlueCross BlueShield of Tennessee Defends New Specialty Drug Policy as Some Legislators Cry FoulJanuary 22nd, 2020
Other Languages
- German
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: